(19)
(11) EP 4 771 139 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24772860.3

(22) Date of filing: 30.08.2024
(51) International Patent Classification (IPC): 
C12N 9/22(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 9/22
(86) International application number:
PCT/US2024/044664
(87) International publication number:
WO 2025/049900 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.09.2023 US 202363580173 P
01.09.2023 US 202363580193 P
15.02.2024 US 202463553840 P
25.04.2024 US 202463638552 P

(71) Applicant: Arbor Biotechnologies, Inc.
Cambridge, MA 02140 (US)

(72) Inventors:
  • ALFONSE, Lauren E.
    Cambridge, Massachusetts 02140 (US)
  • MABEN, Zachary J.
    Cambridge, Massachusetts 02140 (US)
  • TORGERSON, Chad D.
    Cambridge, Massachusetts 02140 (US)
  • WATTERS, Kyle E.
    Cambridge, Massachusetts 02140 (US)

(74) Representative: Maiwald GmbH 
Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) CRISPR NUCLEASE POLYPEPTIDES AND GENE EDITING SYSTEMS COMPRISING SUCH